Xolair (2019-09-06)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Xolair
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| SR532 | - Recalling Firm
- Novartis Pharmaceuticals Canada Inc.
- 2476 Argentia Road, Unit 404
- Mississauga
- L5N 6M1
- Ontario
- CANADA
- Marketing Authorization Holder
- Novartis Pharmaceuticals Canada Inc.
- 385 Bouchard Boulevard
- Dorval
- H9S 1A9
- Quebec
- CANADA
| Xolair | DIN 02260565 | Powder For Solution | Omalizumab 150mg/Vial |
Affected lot may contain the presence of silicone oil.